← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2003Last known activity
Jul 18, 2025
Timeline
1990s
- Jun 1, 1990
Singapore National Eye Centre— Founded
Drugs by trial phase (26 distinct, 24 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Blepharitis
- Choroidal Neovascularization
- Cicatrix
- Cytomegalovirus Infections
- Dry Eye Syndromes
- Edema
- Glaucoma
- Glaucoma, Angle-Closure
- Hypertension
- Iridocyclitis
- Keratoconjunctivitis Sicca
- Macular Degeneration
- Macular Edema
- Myopia
- Neovascularization, Pathologic
- Ocular Hypertension
- Refractive Errors
- Uveitis
- Uveitis, Anterior
- Vascular Diseases
- Xerophthalmia
Recent trials (43)
- NCT07249216Lead sponsorN/AJul 18, 2025
- NCT06765603Sponsor investigatorPhase 2Feb 1, 2025
- NCT06765603Lead sponsorPhase 2Feb 1, 2025
- NCT06731582CollaboratorPhase 3Mar 12, 2024
- NCT05275738CollaboratorN/AMay 18, 2022
- NCT03941587Lead sponsorN/AJun 30, 2019
- NCT03941587Reponsible party - principal investigatorN/AJun 30, 2019
- NCT03768115Lead sponsorEarly Phase 1Nov 1, 2018
- NCT03768115Reponsible party - principal investigatorEarly Phase 1Nov 1, 2018
- NCT03140358Reponsible party - principal investigatorPhase 3Jul 2, 2017
- NCT03140358Lead sponsorPhase 3Jul 2, 2017
- NCT03140358Overall official - principal investigatorPhase 3Jul 2, 2017
- NCT03197480Lead sponsorPhase 4Jul 1, 2017
- NCT03197480Study directorPhase 4Jul 1, 2017
- NCT03117634Lead sponsorPhase 4Jul 1, 2017
Details
- Founded
- Singapore, SG Jun 1, 1990
- Last known activity
- Jul 18, 2025